Differentiation of BCMA-Specific Induced Pluripotent Stem Cells into CD8ab⁺ T Cells Targeting Myeloma

Investigators identified specific transcriptional patterns that could serve as a biomarker for selection of suitable iPSC clones for successful development of antigen-specific CD8αβ+ memory T cells to improve multiple myeloma patient outcome.